Spruce Biosciences, Inc. (SPRB)
USD 0.31
(8.04%)
USD 0.31
(8.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.08 Million | - | - | - | - | - |
| Cost of Revenue | 49.43 Million | 429 Thousand | 381 Thousand | 102 Thousand | 12 Thousand | 1000.00 |
| Gross Profit | -39.34 Million | -429 Thousand | -381 Thousand | -102 Thousand | -12 Thousand | -1000.00 |
| Operating Expenses | 62.08 Million | 47.28 Million | 42.06 Million | 29.41 Million | 13.1 Million | 9.97 Million |
| Selling, General and Administrative Expenses | 12.65 Million | 12.08 Million | 11.36 Million | 5.56 Million | 2.29 Million | 1.56 Million |
| Research and Development Expenses | 49.43 Million | 35.19 Million | 30.69 Million | 23.85 Million | 10.81 Million | 8.4 Million |
| Other Expenses | - | - | 119 Thousand | 200 Thousand | 84 Thousand | 114 Thousand |
| Cost and Expenses | 62.08 Million | 47.28 Million | 42.06 Million | 29.41 Million | 13.1 Million | 9.97 Million |
| Operating Income | -51.99 Million | -47.28 Million | -42.06 Million | -29.41 Million | -13.1 Million | -9.97 Million |
| Interest Expense | 483 Thousand | 420 Thousand | 345 Thousand | 323 Thousand | 65 Thousand | - |
| Income Tax Expense | - | -1.1 Million | 396 Thousand | 487 Thousand | 149 Thousand | 114 Thousand |
| Earnings before Tax | -47.91 Million | -46.18 Million | -42.29 Million | -29.53 Million | -13.08 Million | -9.85 Million |
| Net Income | -47.91 Million | -45.07 Million | -42.68 Million | -30.02 Million | -13.23 Million | -9.85 Million |
| Earnings Per Share Basic | -1.24 | -1.92 | -1.83 | -1.29 | -0.59 | -2.01 |
| Earnings Per Share Diluted | -1.24 | -1.92 | -1.83 | -1.29 | -0.59 | -2.01 |
| Weighted Average Shares Outstanding | 38.51 Million | 23.52 Million | 23.36 Million | 23.26 Million | 22.26 Million | 4.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.51 Million | 23.52 Million | 23.36 Million | 23.26 Million | 22.26 Million | 4.89 Million |
| Gross Margin | -3.90 | - | - | - | - | - |
| EBIT Margin | -4.69 | - | - | - | - | - |
| Profit Margin | -4.75 | - | - | - | - | - |
| EBITDA | -47.36 Million | -45.33 Million | -41.56 Million | -29.11 Million | -13.09 Million | -9.97 Million |
| Earnings Before Tax Margin | -5.15 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.61 Million | 2 Million | 10.08 Million | 2.88 Million | 3.07 Million | 2.16 Million |
| Cost of Revenue | 12 Thousand | 15 Thousand | 70 Thousand | 16 Thousand | 17 Thousand | 74 Thousand |
| Gross Profit | 1.59 Million | 1.98 Million | 10.01 Million | 2.87 Million | 3.05 Million | 2.09 Million |
| Operating Expenses | 11.63 Million | 14.62 Million | 62.01 Million | 14.03 Million | 16.73 Million | 16.13 Million |
| Selling, General and Administrative Expenses | 3.54 Million | 4.3 Million | - | 2.93 Million | 3.23 Million | 3.01 Million |
| Research and Development Expenses | 8.09 Million | 10.31 Million | - | 11.1 Million | 13.49 Million | 13.12 Million |
| Other Expenses | -8.09 Million | - | - | - | - | - |
| Cost and Expenses | 11.64 Million | 14.63 Million | 62.08 Million | 14.05 Million | 16.73 Million | 16.13 Million |
| Operating Income | -10.03 Million | -12.63 Million | -51.99 Million | -11.16 Million | -13.65 Million | -13.97 Million |
| Interest Expense | 83 Thousand | 97 Thousand | 483 Thousand | 106 Thousand | -119 Thousand | 127 Thousand |
| Income Tax Expense | - | -28.27 Thousand | -97.89 Thousand | -963 Thousand | -17 Thousand | 1.25 Million |
| Earnings before Tax | -9.18 Million | -11.62 Million | -47.91 Million | -9.95 Million | -12.35 Million | -12.82 Million |
| Net Income | -9.18 Million | -11.62 Million | -47.91 Million | -9.95 Million | -12.35 Million | -12.82 Million |
| Earnings Per Share Basic | -0.22 | -0.28 | - | -0.24 | -0.30 | -0.32 |
| Earnings Per Share Diluted | -0.22 | -0.28 | - | -0.24 | -0.30 | -0.32 |
| Weighted Average Shares Outstanding | 41.16 Million | 41.09 Million | 38.51 Million | 41.02 Million | 40.71 Million | 40.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.16 Million | 41.09 Million | 38.51 Million | 41.02 Million | 40.71 Million | 40.54 Million |
| Gross Margin | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.97 |
| EBIT Margin | -6.23 | -6.30 | - | -3.86 | -4.44 | -5.86 |
| Profit Margin | -5.70 | -5.81 | -4.75 | -3.45 | -4.02 | -5.92 |
| EBITDA | -10.02 Million | -12.61 Million | - | -11.14 Million | -13.65 Million | -12.69 Million |
| Earnings Before Tax Margin | -6.23 | -6.31 | -5.15 | -3.87 | -4.44 | -6.45 |
FSRL
FNGR
DPZUF
GOLECHA
CHGX
HR